Lunsumio (mosunetuzumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lunsumio (mosunetuzumab), covering 2025-01-24 to 2025-01-24. Get the full timeline:
Most recent: Clinical Trial Update: Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)